Naziv |
Akcije |
Galunić Bilić, Lea ; Šantek, Fedor ; Grah, Josip Joachim ; Bašić-Kinda, Sandra ; Mandac Smoljanović, Inga ; Ostojić Kolonić, Slobodanka ; Mitrović, Zdravko ; Vodanović, Marijo ; Dujmović, Dino ; Aurer, Igor
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience // Radiologia medica, 128 (2023), 1615, 9. doi: 10.1007/s11547-023-01615-8 |
|
(KroHem) Mitrović, Zdravko ; Dujmović, Dino ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Gaćina, Petar ; Periša, Vlatka ; Prka, Željko ; Dreta, Barbara ; Galušić Davor ; Holik, Hrvoje et al.
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7. doi: 10.1111/ejh.13957 |
|
Lucijanić, Marko ; Huzjan Korunić, Renata ; Ivić, Marija ; Fazlić Džankić, Amina ; Jonjić, Željko ; Mitrović, Zdravko ; Prka, Željko ; Piršić, Mario ; Jakšić, Ozren ; Gaćina, Petar et al.
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients // Wiener klinische Wochenschrift, 134 (2022), 1-2; 80-82. doi: 10.1007/s00508-021-01850-x |
|
Aurer, Igor ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Mrđenović, Stefan ; Ostojić Kolonić, Slobodanka ; Lozić, Dominik ; Holik, Hrvoje ; Novaković Coha, Sabina ; Bernes, Petra ; Krečak, Ivan et al.
Purine analogues increase the risk of lethal and/or prolonged COVID19 while obinutuzumab increases the risk of prolonged but not lethal infection in patients treated for lymphoid malignancies - a study of Krohem, the Croatian group for hematologic diseas // Blood. 2021. str. 3553-3553 doi: 10.1182/blood-2021-149613 |
|
Bašić-Kinda, Sandra ; Mišura Jakobac, Karla ; Sinčić-Petričević, Jasminka ; Deak, Dajana ; Vodanović, Marijo ; Jakić-Bubalo, Marinka ; Mitrović, Zdravko ; Grubešić, Aron ; Dreta, Barbara ; Županić Krmek, Dubravka et al.
Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non internventional study of the Croatian Cooperative Group for Hematologic Diseases // Croatian medical journal, 62 (2021), 5; 455-463. doi: 10.3325/cmj.2021.62.455-63 |
|
Radilj, Ivan ; Grabovac, Vlatko ; Mitrović, Zdravko
Characteristics and Outcomes of Patients With Deep Vein Thrombosis Diagnosed in Emergency Department of Clinical Hospital Dubrava During 2019 // Southeastern European medical journal, 5 (2021), 2; 18-26. doi: 10.26332/seemedj.v5i2.214 |
|
Galunić Bilić, Lea ; Šantek, Fedor ; Soče, Majana ; Grah, Josip Joachim ; Bašić Kinda, Sandra ; Radman, Ivo ; Mitrović, Zdravko ; Martinović, Marko ; Aurer, Igor
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients // Radiotherapy and oncology. 2020. str. S486-S486 doi: 10.1016/S0167-8140(21)00927-0 |
|
Pejsa, Vlatko ; Lucijanic, Marko ; Vrkljan Vuk, Anamarija ; Stoos-Veic, Tajana ; Jaksic, Ozren ; Jonjic, Željko ; Pirsic, Mario ; Prka, Željko ; Ivic, Marija ; Fazlic Dzankic, Amina et al.
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemia // Leukemia & lymphoma, 61 (2020), 4; 934-939. doi: 10.1080/10428194.2019.1702182 |
|
Aurer, Igor ; Mišura Jakobac, Karla ; Sinčić- Petricevic, Jasminka ; Deak, Dajana, Vodanović, Mario ; Jakic-Bubalo, Marina ; Mitrović, Zdravko ; Grubesic Aron ; Dreta Barbara ; Zupanic-Krmek, Dubravka, Coha Božena
IMPROVEMENTS IN OUTCOME OF MANTLE-CELL LYMPHOMA (MCL) ARE MOSTLY DUE TO ADVANCES IN INDUCTION THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) - A REAL-LIFE NON- INTERVENTIONAL STUDY OF KROHEM // HemaSphere. 2019. str. 579-579 doi: 10.1097/01.HS9.0000563340.44346.69 |
|
Pulanić, Dražen ; Raos, Mirela ; Vinković, Matea ; Kilić, Paula ; Periša, Vlatka ; Mitrović, Zdravko ; Mandac Rogulj, Inga ; Holik, Hrvoje ; Gverić-Krečak, Velka ; Krečak, Ivan et al.
Prospektivna opservacijska studija KroHem-a o autoimunosnim hemolitičkim anemijama // Bilten Krohema, 13 (2019), 1; 50-51 |
|